We report evidence that gene complexes, consisting of polycations and plasmid DNA enter cells via binding to membrane-associated proteoglycans. 
Because of the current interest in gene therapy, a number of nonviral transfection agents have been developed. Among them are polylysine-(PLL) and lipid-based amphiphiles, which belong to a diverse class of macromolecules that form stable complexes with DNA. At optimum formulations, these agents surround DNA with a net positive charge, that in turn, enable the DNA complex to bind to anionic residues on the cell surface. Following entry into the cell by endocytosis, a fraction of the DNA enters the nucleus and the gene of interest is transcribed (1) .
Despite the advances in this field, few studies have focused on the molecular mechanisms of gene delivery. In particular, the membrane molecules that are responsible for the transfection of cation-DNA complexes have never been investigated. Here, we report evidence that sulfated, membraneassociated proteoglycans serve as a receptor for transfection by PLL and possibly by some cationic lipids.
Sulfated proteoglycans are among the most negatively charged components of the cell. They consist of a core protein covalently linked to one or more sulfated glycosaminoglycans: heparin, heparan sulfate, dermatan sulfate, chondroitan sulfate, and keratan sulfate (2, 3) . Proteoglycan synthesis begins in the endoplasmic reticulum with the formation of the protein core (4, 5) . As the protein core is transported from the rough endoplasmic reticulum to the Golgi, serine residues are linked to D-xylose by xylosyltransferase (6) . The protein core is further modified with two galactosyl residues and a glucuronosyl residue. Starting from this sugar, the glycosaminoglycan backbone is synthesized. Sulfates are transferred from adenosine 3'-phosphate 5'-phosphosulfate by sulfotransferase onto the glycosaminoglycans (7) . Finally, the glycosaminoglycan residues are epimerized before the proteoglycans are exported to their final destination (8, 9) .
Proteoglycans are a fundamental component of basement membranes (10) and the extracellular matrix, and play a pivotal role in cellular proliferation, migration, and differentiation (11, 12) . As integral and glycosylphosphatidyl inositol-linked membrane proteins, heparan sulfate and chondroitan sulfate proteoglycans sequester protease inhibitors, growth factors, and proteases and serve as a receptor for infection by the herpes simplex virus (for reviews, see refs. 13 and 14) .
Because glycosaminoglycans are highly anionic, the interactions between proteoglycans and their ligands occur largely through ionic forces. Based on this information, we proposed that membrane-associated proteoglycans mediate the binding and delivery of cation-DNA complexes into cells. To test this hypothesis, a number of assays were used. Since proteoglycan charge is derived mostly from the sulfation of the glycosaminoglycan chains (2), transfection was assayed in HeLa cells cultured in the presence of sodium chlorate, an inhibitor of glycosaminoglycan sulfation (15) . Transfection was also tested in cells pretreated with glycosaminoglycan lyases to remove extracellular glycosaminoglycans (16) and in the presence of purified glycosaminoglycans. In addition, the transfection efficiency of PLL-and cationic lipid-DNA was tested in wild-type Chinese hamster ovary (CHO) cells and in mutant CHO cells unable to synthesize proteoglycans (17) . To prepare fluorescent DNA, plasmid (100 ,ug/ml) was incubated with a 50-fold molar excess of YOYO-1 (Molecular Probes) and a fluorescent DNA intercalator (19, 20) period, cells were rinsed twice with 1 ml PBS and placed into 1 ml transfection media. Transfection, uptake, or binding experiments immediately followed. The transfection was conducted in the absence of chlorate to minimize the possible effects that this compound might have on cellular processes unrelated to proteoglycans.
MATERIALS AND METHODS
Treatment of Cells with Glycosaminoglycan Lyases and Purified Glycosaminoglycans. HeLa cells were seeded (5 x 104 cells per ml) into 12-well plates (Falcon). Eighteen hours later, cells were rinsed twice with 1 ml PBS and placed into a BSA/PBS solution containing either 10 units/ml chondroitinase ABC (Sigma) or 10 units/ml heparinase II (Sigma) (16) . Cells were incubated with lyases for 1 hr at 22°C. Following the removal of surface glycosaminoglycans, cells were rinsed twice with PBS and transfected according to the usual protocol.
Glycosaminoglycans (chondroitan sulfate A, bovine trachea; chondroitan sulfate B, bovine mucosa; chondroitan sulfate C, shark cartilage; heparan sulfate, bovine trachea; heparin, bovine trachea; hyaluronic acid, bovine mucosa) were purchased from Sigma. To evaluate the effect of free glycosaminoglycans on transfection, DNA complexes and glycosaminoglycans (40 g/ml heparan sulfate, heparin, chondroitan sulfate A, chondroitan sulfate B, chondroitan sulfate C, or hyaluronic acid) were added together at the time of transfection. Transfected cells were treated according to the usual protocol.
Fluorescence Uptake Experiments and Confocal Microscopy. HeLa, CHO-pgs745, and CHO-Kl cells were incubated with PLL-YYDNA for 4 hr and then rinsed three times in PBS. To remove surface bound DNA, cells were treated with DNase (1 mg/ml, Sigma) for 15 min and then detached with trypsin-EDTA. Cell suspensions were pelleted, washed twice in PBS, and fixed in 4% paraformaldehyde/PBS for 10 min at room temperature. After a final rinse in PBS, cell pellets were resuspended in Biomeda/PBS solution (90:10) and mounted between a slide and coverslip. Fluorescence images were obtained using a Bio-Rad confocal microscope.
Binding Assays. Complexes were prepared as described using nick-translated plasmid and then added to cells that were prechilled to 4°C. After a 2-4 hr incubation at this temperature, cells were rinsed four times in ice-cold PBS and detached with trypsin-EDTA. Aliquots were dissolved in Safety Solve scintillation cocktail, radioactivity (counts per min) was quantitated in a Beckman model LS 5000 TD scintillation counter. Cellular protein was determined by the fluoraldehyde assay (Pierce).
RESULTS

PLL-Mediated Transfection Requires Positively Charged
Complexes. The net charge on a DNA complex can significantly influence transfection efficiency. Optimum formulations with cationic lipids consist of a molar excess of positive charge (1) . To determine the optimum charge ratio for PLL, a series of complexes prepared with 1.5 ,ug DNA and varying amounts of PLL were transfected into HeLa cells.
Complexes composed of amine/nucleotide charge ratios < 1 yielded very little expression ( Fig. 1) . Expression increased nonlinearly with PLL concentration and reached a peak (5 x 105 relative light unit/mg cell protein) at a charge ratio (amine/nucleotide) equal to 1.5. Agarose gel electrophoresis confirmed that complexes composed of this ratio were positively charged (data not shown). Cellular uptake assays revealed that this ratio was optimal for cellular uptake of nick-translated and fluorescently labeled DNA. Complexes with ratios larger than 1.5 yielded lower expression values according to previous observations (21) . These results are consistent with the putative ionic model to describe the interactions between the cell membrane and cation-DNA complexes.
Sulfates Mediate PLL-DNA Transfection. The role of proteoglycans in cellular processes has been demonstrated by inhibiting glycosaminoglycan sulfation with sodium chlorate (22, 23) . Chlorate is a nontoxic inhibitor of ATP-sulfurylase, an essential enzyme in the synthesis of 3'-phosphoadenosyl-5'-phosphosulfate, a glycosaminoglycan sulfate donor (15, 24) .
To test the role of sulfated proteoglycans in transfection, cells were grown in the presence of sodium chlorate for 48 hr (Fig. 3A) . The most anionic glycosaminoglycans, heparin and heparan sulfate, nearly eliminated luciferase expression, whereas chondroitans A and C and hyaluronic acid had no effect. Chondroitan sulfate B, the third most anionic glycosaminoglycan, reduced expression by -40%.
Since excess glycosaminoglycans in media have been shown to affect DNA transcription (25) (Fig. 2C) (Fig. 4) (17) .
Both CHO-Kl and CHO-pgs745 cells were transfected with the same amount of DNA and with the same charge ratio, but luciferase expression in proteoglycan-deficient cells was 53x lower than in wild-type cultures (Fig. 5A) . Consistent with previous observations, the uptake of PLL-YYDNA into CHOpgs745 cells was dramatically lower than into CHO-Kl cells (Fig. SB) , and the binding of PLL-32P-DNA to CHO-pgs745 cells was inhibited 80% with respect to wild-type CHO cells (data not shown).
Role of Proteoglycans in Cationic Lipid-Mediated Transfection. The experiments described support the hypothesis that membrane-associated proteoglycans mediate the delivery of PLL-DNA. In practice, unmodified PLL is not a widely used agent for transfection, because the transfection efficiency is low compared with cationic lipids. To evaluate the role of proteoglycans in a more common transfection system, the transfection efficiency of a series of cationic lipids (PerFect Transfection kit, Invitrogen) was tested in wild-type and mutant CHO cells. The formulations tested were either a mixture of two cationic lipids (pfx-1), a 1:1 mixture of dioleoylphosphatidylethanolamine (DOPE)/cationic lipid (pfx-6 and pfx-7), or a single cationic lipid (pfx-8).
Each formulation was transfected into CHO-Kl and CHOpgs745 cells (-2 x 105 cells per well) using 4 jig DNA and the optimum amount of lipid (as determined by the manufacturer). Cells were exposed to lipid-DNA complexes for 4 hr in serum-free Ham's F-12 media, rinsed twice with PBS, and incubated in regular growth media. Twenty hours later, a significant number of dead cells and cellular debris was observed especially in cultures transfected with pfx-7 and pfx-8. Cationic liposome induced toxicity has been observed previously, although the reasons for this toxicity are unclear.
To eliminate the possible artifacts that might arise from toxicity, cells were transfected again with a 20-fold lower concentration of lipid-DNA. At these concentrations, very few dead cells were observed in any of the cultures. Following the transfection, all cultures were rinsed and assayed for luciferase activity.
A correlation quotient, X, defined as (relative light units in wild-type cells/relative light units in mutant cells) was plotted for each type of lipid (Fig. 6) Fig. 1. (B) Cells were prepared and imaged as described (Fig. 2B) 4 hr in serum-free Ham's F-12 media, rinsed twice with PBS, and incubated in regular growth media for an addition 20 hr. Luciferase expression in cellular lysates was determined as described ( Fig. 1) .
We also demonstrated that exogenous heparin and heparan sulfate preferentially inhibited transfection, probably by binding and destabilizing complexes in solution and preventing intact complexes from entering the cell. These results do not directly support a role for membrane-associated proteoglycans in transfection but explain why heparin is a serious inhibitor of transfection and also support the results of recently published work in this area (26) . Since the least anionic glycosaminoglycans, the chondroitan sulfates, had very little effect on transfection and dextran sulfate, an anionic glycosaminoglycan analog, dramatically inhibited transfection, the inhibition by heparin and heparan sulfate proteoglycans is probably a nonspecific effect, dependent on charge effects rather than on structural features.
However, direct evidence was found to implicate mem- 12354 Cell Biology: Mislick and Baldeschwieler weakest correlation and the lowest expression levels were obtained with lipid formulations consisting of a 1:1 mixture of a cationic lipid and DOPE or a single cationic lipid. Experiments were not conducted to verify that the inhibition of expression was directly caused by decreased binding and uptake of lipid-DNA, but they are currently in progress. These preliminary results are consistent with the hypothesis that proteoglycans participate in the transfection of certain cationic lipids, but we cannot conclude yet that other mechanisms do not play an important role. Future studies will be conducted to test the role of proteoglycans in the transfection by cationic lipids of known structure so that a correlation between proteoglycan-mediated transfection and precise structural features can be elucidated.
In conclusion, we suggest that the variable expression of proteoglycans among tissues may explain why some cell types are more susceptible to transfection than others. Although all tissues express proteoglycans to some level (27) , proteoglycan expression is regulated by both the state of differentiation and growth of the cell. Immature myeloid and lymphoid cells express the hematopoietic proteoglycan core protein (HpPG) at low levels only but up-regulate the HpPG gene 10-fold upon differentiation (28) . Recently, the undifferentiated erythroleukemia cell line, K562, was shown to express 2-3 times more of the basement membrane proteoglycan, perlecan, if the cells were artificially stimulated to differentiate with 12-0-tetradecanoylphorbol-13-acetate, a phorbol diester (29) . Incidentally, K562 cells are one of the most difficult cell lines to transfect by cationic methods but yield high levels of expression by transferrin-PLL transfection (30) . This implies that the susceptibility of a cell type to transfection may partially depend on the mechanism of entry and not entirely on intracellular factors. The development of methods to increase expression in these hematopoietic cell lines is important for ex vivo applications of gene replacement therapy. Experiments that attempt to modulate proteoglycan expression as a means to increase transfection by cationic methods are currently in progress.
Finally, these experiments bring to light the possible barriers that might be encountered by gene delivery in vivo. The inhibition of transfection by heparin and other charged components in serum has been established (31) . This problem is avoided in vitro by conducting transfection experiments in serum-free media. Although typical concentrations of heparin in blood are low, the presence of heparin combined with other charged serum components might seriously affect transfection in vivo. Gene delivery might also be inhibited by wasteful binding of DNA complexes to the extracellular matrix and to basement membranes of tissues in the body. If these problems prove to be significant in vivo, then alternative gene delivery vectors that are are optimized at more neutral charge ratios may have to be developed.
